share_log

Biora Therapeutics Showcases Progress On BioJet Oral Delivery Platform With Largest Payload Capacity Among Ingestible Injectables At PODD Meeting; Smaller 00-Size Device Advances In Animal Models With Full Testing Expected In Q4 2024

Biora Therapeutics Showcases Progress On BioJet Oral Delivery Platform With Largest Payload Capacity Among Ingestible Injectables At PODD Meeting; Smaller 00-Size Device Advances In Animal Models With Full Testing Expected In Q4 2024

Biora Therapeutics在PODD會議上展示了BioJet口服給藥平台的進展,該平台具有可食用注射劑中最大的有效載荷容量;較小的00尺寸裝置在動物模型中取得進展,預計將在2024年第4季度進行全面測試。
Benzinga ·  10/28 20:13

Biora Therapeutics Showcases Progress On BioJet Oral Delivery Platform With Largest Payload Capacity Among Ingestible Injectables At PODD Meeting; Smaller 00-Size Device Advances In Animal Models With Full Testing Expected In Q4 2024

Biora Therapeutics在PODD會議上展示了BioJet口服給藥平台的進展,該平台具有可食用注射劑中最大的有效載荷容量;較小的00尺寸裝置在動物模型中取得進展,預計將在2024年第4季度進行全面測試。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論